Literature DB >> 3413981

Association of soluble matrix protein of Newcastle disease virus with liposomes is independent of ionic conditions.

K S Faaberg1, M E Peeples.   

Abstract

An immunoaffinity method was designed for purification of a soluble form of the matrix (M) protein of Newcastle disease virus. The resulting M protein sedimented in a sucrose gradient as a small complex. This purified M protein associated with liposomes containing a net neutral, negative, or positive charge. The liposomes were composed of phosphatidylcholine, cholesterol, and a third lipid which provided the charge. The M protein-liposome associations were not prevented by high salt conditions. These observations are consistent with a nonelectrostatic association between the M protein and liposomes. Monoclonal antibodies to three separate epitopes of the M protein were all able to bind M protein complexed with liposomes, suggesting that the three M protein epitopes are not directly involved in the interaction between the M protein and liposomes. The M protein was also able to associate with liposomes lacking cholesterol implying that cholesterol does not play a substantial role in the M protein-liposome interaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413981     DOI: 10.1016/0042-6822(88)90153-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction.

Authors:  Victoria A Money; Helen K McPhee; Jackie A Mosely; John M Sanderson; Robert P Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

Review 2.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

3.  Solution Structure, Self-Assembly, and Membrane Interactions of the Matrix Protein from Newcastle Disease Virus at Neutral and Acidic pH.

Authors:  E V Shtykova; M V Petoukhov; L A Dadinova; N V Fedorova; V Yu Tashkin; T A Timofeeva; A L Ksenofontov; N A Loshkarev; L A Baratova; C M Jeffries; D I Svergun; O V Batishchev
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Solubility of vesicular stomatitis virus M protein in the cytosol of infected cells or isolated from virions.

Authors:  B J McCreedy; K P McKinnon; D S Lyles
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Identification and partial purification of the fusion protein of avian paramyxovirus type 3.

Authors:  C L Anderson; P H Russell
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo.

Authors:  C M Sanderson; H H Wu; D P Nayak
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Sendai virus assembly: M protein binds to viral glycoproteins in transit through the secretory pathway.

Authors:  C M Sanderson; N L McQueen; D P Nayak
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Assembly and biological and immunological properties of Newcastle disease virus-like particles.

Authors:  Lori W McGinnes; Homer Pantua; Jason P Laliberte; Kathryn A Gravel; Surbhi Jain; Trudy G Morrison
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

9.  Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization.

Authors:  Michael J Norris; Monica L Husby; William B Kiosses; Jieyun Yin; Roopashi Saxena; Linda J Rennick; Anja Heiner; Stephanie S Harkins; Rudramani Pokhrel; Sharon L Schendel; Kathryn M Hastie; Sara Landeras-Bueno; Zhe Li Salie; Benhur Lee; Prem P Chapagain; Andrea Maisner; W Paul Duprex; Robert V Stahelin; Erica Ollmann Saphire
Journal:  Sci Adv       Date:  2022-07-20       Impact factor: 14.957

10.  Membrane association of functional vesicular stomatitis virus matrix protein in vivo.

Authors:  L D Chong; J K Rose
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.